chr1:155234452:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:155,204,243-155,214,490 |
hg38 | chr1:155,234,452-155,244,699 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.441 | Gaucher Disease, Type 2 (disorder) | A novel complex allele and two new point mutations in type 2 (acute neuronopathi... | UNIPROT | 9851895 | Detail |
<0.001 | Constipation | NA | BeFree | Detail | |
<0.001 | Presenile dementia | NA | BeFree | Detail | |
0.003 | Epilepsies, Myoclonic | NA | LHGDN | Detail | |
0.355 | Gaucher disease | Gaucher disease (GD) is the most common glycolipid storage disorder resulting fr... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24522292 | Detail |
0.355 | Gaucher disease | Recent discovery of clinical, genetic, and pathological linkage between GD and P... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24668939 | Detail |
0.355 | Gaucher disease | Gaucher disease (GD) is an autosomal recessive disorder caused by mutations in t... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24801745 | Detail |
0.355 | Gaucher disease | From the first descriptions of Parkinson's disease (PD) and Gaucher's disease (G... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24894157 | Detail |
0.355 | Gaucher disease | Mutations in the gene that encodes the lysosomal enzyme acid β-glucosidase lead ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24894562 | Detail |
0.355 | Gaucher disease | Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lyso... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24905578 | Detail |
0.355 | Gaucher disease | Saposin (Sap) C is an essential cofactor for the lysosomal degradation of glucos... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24925315 | Detail |
0.355 | Gaucher disease | A Phase 3, multicenter, open-label, switchover trial to assess the safety and ef... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 24950666 | Detail |
0.355 | Gaucher disease | Mutations in β-glucocerebrosidase, the genetic defect in Gaucher disease (GD), a... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25111979 | Detail |
0.355 | Gaucher disease | Gaucher's disease is a hereditary deficiency of the enzyme β-glucocerebrosidase ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25126987 | Detail |
0.355 | Gaucher disease | Although infusions of recombinant GBA ameliorate the systemic effects of GD, thi... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25416676 | Detail |
0.355 | Gaucher disease | Lysosomal glucosidase beta acid (GBA) deficiency is inherent to Gaucher disease,... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25552189 | Detail |
0.355 | Gaucher disease | Homozygous mutations in GBA1 cause Gaucher disease, the most common lysosomal st... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25813221 | Detail |
0.355 | Gaucher disease | In the last decade, several lines of evidence have been presented that document ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25987177 | Detail |
0.355 | Gaucher disease | These data provide new insights into the mechanisms involved in the intracellula... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 26018676 | Detail |
0.355 | Gaucher disease | The diversity of GBA gene mutations from patients with Gaucher disease represent... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 26096741 | Detail |
<0.001 | Hepatosplenomegaly | Insufficient glucosylceramidase activity results in hepatosplenomegaly, cytopeni... | BeFree | 25655314 | Detail |
0.002 | Hypergammaglobulinemia | NA | GAD | Detail | |
0.120 | pulmonary hypertension | NA | BeFree,CTD_human | Detail | |
<0.001 | Congenital ichthyosis | NA | BeFree | Detail | |
0.001 | lymphoma | Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be sep... | BeFree | 24887457 | Detail |
0.001 | lymphoma | Here, we identified candidate genes which were upregulated after an epigenetic t... | BeFree | 25226156 | Detail |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
<0.001 | Metabolic Diseases | Gaucher disease (GD) is an inherited metabolic disorder caused by mutations in t... | BeFree | 25416676 | Detail |
0.003 | multiple myeloma | NA | BeFree,GAD | Detail | |
<0.001 | Muscle Rigidity | NA | BeFree | Detail | |
0.003 | nervous system disorder | NA | BeFree,GAD | Detail | |
0.003 | Niemann-Pick Diseases | NA | LHGDN | Detail | |
<0.001 | kidney failure | These data provide new insights into the mechanisms involved in the intracellula... | BeFree | 26018676 | Detail |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | Congenital Nonbullous Ichthyosiform Erythroderma | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.005 | diffuse large B-cell lymphoma | Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be sep... | BeFree | 24887457 | Detail |
0.007 | Lysosomal Storage Diseases | Mutations in the gene that encodes the lysosomal enzyme acid β-glucosidase lead ... | BeFree | 24894562 | Detail |
0.007 | Lysosomal Storage Diseases | Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lyso... | BeFree | 24905578 | Detail |
<0.001 | Muscular stiffness | NA | BeFree | Detail | |
<0.001 | Bradykinesia | NA | BeFree | Detail | |
0.005 | Parkinsonian Disorders | In this review, we (i) outline how GBA was identified as a genetic risk factor f... | BeFree,LHGDN | 24894157 | Detail |
<0.001 | Ichthyosis linearis circumflexa | NA | BeFree | Detail | |
0.002 | Impaired cognition | The GBA-associated PD patients compared with non-mutation PD patients, although ... | BeFree | 25448271 | Detail |
0.003 | multiple system atrophy | NA | BeFree,GAD | Detail | |
<0.001 | Motor symptoms | This study was undertaken to evaluate progression of motor and non-motor symptom... | BeFree | 25448271 | Detail |
<0.001 | dementia | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | From a translational perspective, we discuss how various therapeutic approaches ... | BeFree | 25573151 | Detail |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Action myoclonus-renal failure syndrome | NA | BeFree | Detail | |
0.133 | Lewy Body Disease | We have previously shown that the p.N370S variant in GBA is associated with DLB,... | BeFree,CTD_human,GAD,LHGDN | 24973356 | Detail |
0.133 | Lewy Body Disease | Lysosomal glucosidase beta acid (GBA) deficiency is inherent to Gaucher disease,... | BeFree,CTD_human,GAD,LHGDN | 25552189 | Detail |
0.133 | Lewy Body Disease | Despite the wealth of experimental, clinical and genetic evidence that supports ... | BeFree,CTD_human,GAD,LHGDN | 25573151 | Detail |
0.133 | Lewy Body Disease | The high level of lysosomal enzymes activity observed in substantia nigra, toget... | BeFree,CTD_human,GAD,LHGDN | 25881142 | Detail |
<0.001 | Activated B-Cell-Like Diffuse Large B-Cell Lymphoma | NA | BeFree | Detail | |
0.445 | Gaucher Disease, Type 1 | Gaucher disease (GD) is the most common glycolipid storage disorder resulting fr... | BeFree,CLINVAR,MGD,ORPHANET,UNIPROT | 24522292 | Detail |
0.445 | Gaucher Disease, Type 1 | Loss of lysosomal glucocerebrosidase (GBA1) function is responsible for several ... | BeFree,CLINVAR,MGD,ORPHANET,UNIPROT | 25326392 | Detail |
0.120 | Gaucher-like disease | NA | ORPHANET | Detail | |
0.445 | Gaucher Disease, Type 1 | Analysis and classification of 304 mutant alleles in patients with type 1 and ty... | UNIPROT | 10796875 | Detail |
<0.001 | Alzheimer's disease | A lipidomic analysis was also performed in brain autopsies (n = 67) which includ... | BeFree | 25933391 | Detail |
<0.001 | anemia | NA | BeFree | Detail | |
<0.001 | Bone Diseases | Insufficient glucosylceramidase activity results in hepatosplenomegaly, cytopeni... | BeFree | 25655314 | Detail |
0.002 | Metabolic Bone Disorder | NA | GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gaucher disease (GD) is the most common glycolipid storage disorder resulting from glucocerebrosidas... | DisGeNET | Detail |
Recent discovery of clinical, genetic, and pathological linkage between GD and PD offers a unique op... | DisGeNET | Detail |
Gaucher disease (GD) is an autosomal recessive disorder caused by mutations in the acid β-glucocereb... | DisGeNET | Detail |
From the first descriptions of Parkinson's disease (PD) and Gaucher's disease (GD) in the nineteenth... | DisGeNET | Detail |
Mutations in the gene that encodes the lysosomal enzyme acid β-glucosidase lead to reduced cellular ... | DisGeNET | Detail |
Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lysosomal storage disord... | DisGeNET | Detail |
Saposin (Sap) C is an essential cofactor for the lysosomal degradation of glucosylceramide (GC) by g... | DisGeNET | Detail |
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucer... | DisGeNET | Detail |
Mutations in β-glucocerebrosidase, the genetic defect in Gaucher disease (GD), are an important susc... | DisGeNET | Detail |
Gaucher's disease is a hereditary deficiency of the enzyme β-glucocerebrosidase (GCase) that is most... | DisGeNET | Detail |
Although infusions of recombinant GBA ameliorate the systemic effects of GD, this therapy has no eff... | DisGeNET | Detail |
Lysosomal glucosidase beta acid (GBA) deficiency is inherent to Gaucher disease, Parkinsonism and Le... | DisGeNET | Detail |
Homozygous mutations in GBA1 cause Gaucher disease, the most common lysosomal storage disease, while... | DisGeNET | Detail |
In the last decade, several lines of evidence have been presented that document the clinical manifes... | DisGeNET | Detail |
These data provide new insights into the mechanisms involved in the intracellular trafficking of GCa... | DisGeNET | Detail |
The diversity of GBA gene mutations from patients with Gaucher disease represented in the ICGG Gauch... | DisGeNET | Detail |
Insufficient glucosylceramidase activity results in hepatosplenomegaly, cytopenias, and bone disease... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be separated into two subt... | DisGeNET | Detail |
Here, we identified candidate genes which were upregulated after an epigenetic treatment of B-cell l... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gaucher disease (GD) is an inherited metabolic disorder caused by mutations in the glucocerebrosidas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These data provide new insights into the mechanisms involved in the intracellular trafficking of GCa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be separated into two subt... | DisGeNET | Detail |
Mutations in the gene that encodes the lysosomal enzyme acid β-glucosidase lead to reduced cellular ... | DisGeNET | Detail |
Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lysosomal storage disord... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this review, we (i) outline how GBA was identified as a genetic risk factor for Parkinsonism, (ii... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The GBA-associated PD patients compared with non-mutation PD patients, although younger and with an ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study was undertaken to evaluate progression of motor and non-motor symptoms in sporadic PD pat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
From a translational perspective, we discuss how various therapeutic approaches to lysosomal dysfunc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have previously shown that the p.N370S variant in GBA is associated with DLB, which, together wit... | DisGeNET | Detail |
Lysosomal glucosidase beta acid (GBA) deficiency is inherent to Gaucher disease, Parkinsonism and Le... | DisGeNET | Detail |
Despite the wealth of experimental, clinical and genetic evidence that supports the association betw... | DisGeNET | Detail |
The high level of lysosomal enzymes activity observed in substantia nigra, together with the selecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gaucher disease (GD) is the most common glycolipid storage disorder resulting from glucocerebrosidas... | DisGeNET | Detail |
Loss of lysosomal glucocerebrosidase (GBA1) function is responsible for several organ defects, inclu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease... | DisGeNET | Detail |
A lipidomic analysis was also performed in brain autopsies (n = 67) which included LBD (n = 34), ADL... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Insufficient glucosylceramidase activity results in hepatosplenomegaly, cytopenias, and bone disease... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs1141808 dbSNP
- Genome
- hg38
- Position
- chr1:155,234,452-155,244,699
- Variant Type
- snv
Genome browser